Vaccinating cattle against E.coli could cut human cases of infections by 85 percent - Article Example

Vaccinating cattle against E.coli could cut human cases of infections by 85 percent. The article to be summarized in this case is, Louis et al., “Predicting the public health benefit of vaccinating cattle against Escherichia coli O157.” The independent variable in this article is testing whether a bacterium causing stern gastrointestinal sickness is brought about by contacting dung from livestock or taking contaminated food and water. The dependent variable is the effect that cattle have been confirmed to be the main reservoir for the growth of the bacterium.

The hypothesis of the study is that the danger of E.coli infection is more vulnerable during the super-shedding period by the cattle. When the excretion from the cattle contain high percentage of the bacteria, the infection becomes significant. Nevertheless, there are vaccines, which reduce super-shedding in cattle. The findings of the study were that the vaccination of the cattle is likely to reduce human cases by approximately 85 percent. This is a strong figure supporting the adoption of the vaccine by livestock industries.

Various countries like Scotland have engaged in research to establish an economic program for similar vaccination programmes. The aim of these countries is to develop more effective vaccines, which will reduce the impact of the bacterium on human life. Treating the cattle to cut down the number of human infection is justifiable, but there is need to put more effort in implementing the program and meeting the costs of the program. Public health has to be taken seriously to achieve this perspective.

The hypothesis of the article was supported because nations across the world are responding positively to the implementation of the program. For instance, Scotland tackles an average of 235 culture positive cases of infections resulting from E.coli. This application continues to be extended to various nations for adoption. For example, the vaccine has been taken up in US. A version in US is not fully licensed yet the authority insists that veterinary medicines must indicate the improvement of human health.

Works CitedLouis, Matthews, Reeve, George, Gally, David L. Low, C. Woolhouse, Mark, McAteer, S. P. Locking, M. E. Chase-Topping, Margo, Haydon, Daniel, Allison, L. J. Hanson, G. Gunn, Joshua, and Reid, S. “Predicting the public health benefit of vaccinating cattle against Escherichia coli O157”. Proceedings of the National Academy of Sciences, 2013; DOI: 10.1073/pnas.1304978110